BioMed Research International

Research Article

JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in T Cells in Renal Cell Carcinoma Patients

Table 1

HLA-class I genotyping of RCC patients and healthy donors.
HLA-AHLA-BHLA-Cw
RCC1030124020702080107020702
Donor 1a030124020702080107020702
Donor 1b030124020702080107020702
RCC2030124021806350604010702
Donor 2030124021806350604010702
RCC3240233023506650604010702
Donor 3240233023506650604010702
RCC4030124021806350604010702
Donor 4030124021806350604010702
RCC50201283506510404010702
Donor 50201283506510404010702